Sandeep Laumas

Insider Reports History

Location
8480 Honeycutt Rd, Suite 200, Raleigh, NC
Signature
/s/ Sandeep Laumas, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandeep Laumas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Hillstream BioPharma Inc. 10%+ Owner Common stock 636K $320K $0.50 Jan 11, 2022 Indirect
Instil Bio, Inc. CFO and CBO Common Stock 0 $0 $23.88 Sep 10, 2025 Direct
Unicycive Therapeutics, Inc. Director Stock Options 41.3K Jul 28, 2025 Direct
Instil Bio, Inc. CFO and CBO Employee Stock Option (right to buy) 30K Sep 10, 2025 Direct
BioXcel Therapeutics, Inc. Director Stock Option (Right to Buy) 17K Jun 10, 2024 Direct

Insider Reports Filed by Sandeep Laumas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TIL Instil Bio, Inc. Sep 10, 2025 6 -$340K 4 Sep 12, 2025 CFO and CBO
UNCY Unicycive Therapeutics, Inc. Jul 28, 2025 1 $0 4 Jul 30, 2025 Director
TIL Instil Bio, Inc. Apr 25, 2025 1 $0 4 Apr 28, 2025 CFO and CBO
TIL Instil Bio, Inc. Sep 18, 2024 1 $0 4 Sep 23, 2024 CFO and CBO
BTAI BioXcel Therapeutics, Inc. Jun 10, 2024 1 $0 4 Jun 11, 2024 Director
TIL Instil Bio, Inc. Feb 10, 2024 1 $0 4 Feb 13, 2024 CFO and CBO
UNCY Unicycive Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 Director
BTAI BioXcel Therapeutics, Inc. Jun 26, 2023 1 $0 4 Jun 28, 2023 Director
TIL Instil Bio, Inc. Jan 8, 2023 1 $0 4 Jan 20, 2023 CFO and CBO
BTAI BioXcel Therapeutics, Inc. May 19, 2022 1 $0 4 May 23, 2022 Director
TIL Instil Bio, Inc. Mar 4, 2022 1 $0 4/A Jan 20, 2023 CFO and CBO
THAR Hillstream BioPharma Inc. Jan 11, 2022 0 $0 3 Jan 11, 2022 10%+ Owner
UNCY Unicycive Therapeutics, Inc. Jul 12, 2021 0 $0 3 Jul 12, 2021 Director
BTAI BioXcel Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director
TIL Instil Bio, Inc. May 11, 2021 1 $0 4 May 13, 2021 CFO and CBO